Far-UVC for healthcare
Continuous bioburden reduction while patients and staff are present
The UV222 filtered far-UVC solution by UV Medico, designed for occupied clinical areas, provides continuous and effective decontamination in healthcare environments without disrupting patient care.
Filtered far-UVC inactivates a wide spectrum of susceptible microorganisms, including MRSA, Candida auris and coronaviruses. It adds a continuous layer between periodic cleaning, without disrupting clinical activity..
Continuous Microbial Reduction in the Presence of People
Inactivation of airborne viruses up to 99.9%, including SARS-COV-2.
Air Changes Equivalents per hour (eACH)
Reduces spread of infection of colds, flu and other viruses. Read more.
Mercury-Free and Environmentally Friendly
Zero Mercury, no chemicals, 12 watt power consumption and UL867 Ozone Compliant. Read more.
Product Lifetime
Our technology exceeds the industry lifetime standards by more than 13.000 hours.
UV Medico Healthcare Products
Reduce Risk of Hospital-Acquired Infections
Reducing the risk of Hospital-Acquired Infections (HAIs) is essential in operating rooms, where surgical site infections (SSIs) pose significant risks to patients. SSIs can cause complications, prolong hospital stays, and increase costs.
UV222 technology uses a specific Far-UVC wavelength at 222 nm to effectively destroy bacteria, viruses, and fungi, without harming human tissues when applied within regulatory limits. By integrating UV222 into operating rooms, microbial levels on surfaces and in the air are significantly reduced, lowering the risk of SSIs.
This advancement offers a continuous, automated alternative to traditional methods, aligning with the healthcare industry’s push towards innovative patient safety measures. UV222 technology is transforming the fight against SSIs and other HAIs.
Far-UVC against Candida auris and other fungi
Candida auris a multidrug-resistant yeast that persists on hospital surfaces, resists many common disinfectants and spreads between cleaning cycles. It is classed as a critical-priority fungal pathogen by the WHO and as an urgent threat by the US CDC.
Filtered 222 nm far-UVC inactivates C. auris on exposed surfaces under tested conditions, and no acquired resistance to 222 nm has been demonstrated. What sets UV222 apart is that it works continuously while patients and staff are present, so it keeps reducing C. auris in patient rooms, bathrooms and ICU bays in the hours between cleaning, when other measures are not active. It adds to cleaning, screening and isolation, with no extra work for clinical or cleaning staff.
How UV Medico's UV222 Products Keep Healthcare Facilities Safe
Our cutting-edge Far-UVC technology, UV222, revolutionizes decontamination with its ability to combat a wide array of pathogens, including antimicrobial resistant bacteria and viruses. By reducing bioburden in patient care areas, we set new cleanliness and safety standards in healthcare environments.
What sets our UV222 technology apart is its ability to provide continuous, real-time decontamination without disrupting the essential and life-saving work performed by healthcare professionals. UV222 operates continuously and seamlessly within busy healthcare settings, without requiring intervention from healthcare professionals.
Moreover, prioritizing patient safety, our technology not only prevents pathogen spread but also protects the most vulnerable patients, marking a significant advancement in creating safer, more resilient healthcare systems ready to face current and future challenges.
Mitigate the Spread of Multi-Resistant Bacteria like MRSA
As antibiotic resistance intensifies, creating a global health crisis, our advanced UV222 systems offer a viable solution against multi-drug resistant bacteria. These superbugs, responsible for millions of deaths annually, are effectively inactivated by our technology.
UV222 allows for continuous decontamination of air and surfaces in occupied hospital environments. It is a game-changer for complying with rigorous hospital hygiene standards.
Extensive research has confirmed the efficacy of UV Medico’s UV222 solutions in disrupting the DNA and RNA of drug-resistant bacteria, preventing their replication, and spread. This non-invasive, environmentally friendly technology marks a significant advancement in the fight against antibiotic resistance.
Protecting the Most Vulnerable: UV222's Role in Safer Healthcare Environments
In modern healthcare, protecting vulnerable patients from infections is crucial.
UV222 technology is designed to safely and effectively neutralize harmful pathogens, reducing the risk of healthcare-associated infections (HAIs) in sensitive environments such as neonatal and intensive care units (ICUs), as well as oncology departments. This innovative decontamination method supports critical care areas by ensuring continuous protection without posing risks to patients or healthcare providers when applied within regulatory limits.
UV Medico’s adoption of Far-UVC technology in the UV222 solutions enhances infection control measures, helping hospitals safeguard the health of their most susceptible patients, comply with high hygiene standards, and improve overall care quality.
Mercury-Free 222 nm Far-UVC KrCl Lamps
UV222 uses a krypton chloride (KrCl) excimer lamp that contains no mercury, unlike conventional 254 nm low-pressure mercury UV lamps.
Mercury-free lamps require no special handling if a lamp breaks, no hazardous-waste disposal at end of life, and fit with tightening restrictions on mercury in lighting under the EU RoHS Directive and the Minamata Convention.
- NEW WHITEPAPER FROM UV MEDICO -
Sustainable Healthcare with Far-UVC
Fill out the form and get your copy now!
Latest Healthcare News from UV Medico
2 min read
World Premiere at MEDICA 2025: UV Medico Launches Revolutionary Instrument Table Light Designed to Reduce SSIs
Søren Aggerholm: Nov 17, 2025
3 min read
Why Far-UVC Can Be Used in Occupied Spaces
Emilie Hage Mogensen: Jun 16, 2025
1 min read
New UV222™ Installation: Ibrahim Bin Hamad Obaidullah Hospital in UAE
Julio Azevedo: Jun 12, 2025
.png)
.png)

.png)
.png)



.png)




